Central Nervous System Involvement as Outcome Measure for Clinical Trials Efficacy in Myotonic Dystrophy Type 1.

Simoncini, Costanza; Spadoni, Giulia; Lai, Elisa; Santoni, Lorenza; Angelini, Corrado; Ricci, Giulia; Siciliano, Gabriele

Simoncini, Costanza; Spadoni, Giulia; Lai, Elisa; Santoni, Lorenza; Angelini, Corrado; Ricci, Giulia; Siciliano, Gabriele.

Afiliação

Simoncini C; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Spadoni G; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Lai E; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Santoni L; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Angelini C; IRCCS S.Camillo Hospital, Venice, Italy.
Ricci G; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Siciliano G; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Front Neurol ; 11: 624, 2020.

Article em En | MEDLINE | ID: mdl-33117249

Palavras-chave

central nervous system; clinical trials; myotonic dystrophy type 1; neuroimaging; neuropsychological outcome measures

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Front Neurol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google